Compounds > 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea
Page last updated: 2024-08-23

1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Astrocytoma, Grade IV

1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacPherson, JS; Miller, JD; Smyth, JF; Whittle, IR1

Other Studies

1 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Astrocytoma, Grade IV

ArticleYear
The disposition of TCNU (tauromustine) in human malignant glioma: pharmacokinetic studies and clinical implications.
    Journal of neurosurgery, 1990, Volume: 72, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Brain; Brain Neoplasms; Female; Glioblastoma; Humans; Intracranial Pressure; Male; Middle Aged; Nitrosourea Compounds; Taurine

1990